AUTL Q1 2026 Earnings Biotech Posts WiderThanExpected Loss as Stock Edges Higher BNTX Q1 2026 Earnings NarrowerThanExpected Loss as BioNTech Focuses on Pipeline Progress CLBT Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response LDOS Q1 2026 Earnings EPS Beats Estimates by Nearly 6 as Stock Rises UFP Technologies Q1 2026 Earnings EPS Misses Estimates Amid Slight Stock Gains Natuzzi NTZ Edges Higher Testing Key Resistance Amid Modest Gains Orrstown Financial Services ORRF Edges Higher With Measured Upside Potential Merck Co MRK Rallies 564 as Buyers Step In Above Key Support PMV Pharmaceuticals PMVP Slips to 126 as Cautious Trading Puts Support to the Test BH Q1 2025 Earnings EPS of 2337 Reported Amid Limited Disclosure M Q1 2026 Earnings EPS Beats Estimates by 673 as Stock Declines NVVE Q2 2025 Earnings Wide Loss Reported Amidst Operational Challenges Stock Gains 69 Tyra Biosciences Q1 2026 Earnings Missed EPS Estimates Amid PreRevenue Stage IMRX Q1 2026 Earnings EPS Surpasses Estimates as Clinical Pipeline Advances CIMN Q1 2026 Earnings EPS Beats Estimates Amid Steady Performance FRSX Q3 2021 Earnings EPS Surprises Positive Amid PreRevenue Development Stage Quaker Houghton Q1 2026 Earnings Marginal EPS Miss Amid Mixed Market Signals